
Botanix Pharmaceuticals
A clinical-stage pharmaceutical company developing novel dermatological and antimicrobial treatments for common skin diseases, leveraging a proprietary drug delivery system.
Market cap
$184m
Enterprise value
$153m
Share price
AUD0.15 BOT.AX
Authorizing premium user...